Chinese Journal of New Drugs and Clinical Remedies
|
2024, 43(7): 556-560
• Rational Drug Use •
Two cases of immune-related diabetic ketoacidosis induced by tislelizumab
Full
Dan MEI
a, Jun GONG
b, Hui-fang WANG
a, Mei-xin NI
a
Affiliations
- a.Department of Pharmacy, Affiliated Tumor Hospital of Nantong University, Nantong JIANGSU 226361, China
- b.Department of Medical Oncology, Affiliated Tumor Hospital of Nantong University, Nantong JIANGSU 226361, China
Published: 2024-07-25
doi: 10.14109/j.cnki.xyylc.2024.07.14
Outline
tislelizumab
/
diabetes mellitus
/
diabetic ketoacidosis
/
programmed cell death 1 receptor
/
adverse drug reactions
Dan MEI, Jun GONG, Hui-fang WANG, Mei-xin NI.
Two cases of immune-related diabetic ketoacidosis induced by tislelizumab[J].
Chinese Journal of New Drugs and Clinical Remedies,
2024
, 43
(7)
: 556
-560
.
DOI: 10.14109/j.cnki.xyylc.2024.07.14
Year 2024 volume 43 Issue 7
PDF
97
48
Cite this Article
BibTeX
Article Info
doi: 10.14109/j.cnki.xyylc.2024.07.14
- Receive Date:2022-04-29
- Online Date:2026-03-13
- Published:2024-07-25